Search This Blog

Thursday, February 27, 2020

Orchard Therapeutics EPS misses by $0.02, misses on revenue

Orchard Therapeutics (NASDAQ:ORTX): Q4 GAAP EPS of -$0.46 misses by $0.02.
Revenue of $0.6M (-13.0% Y/Y) misses by $0.4M.
Press Release
https://seekingalpha.com/news/3546370-orchard-therapeutics-eps-misses-0_02-misses-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)